Table 2.
Male recipients—pre heart transplantation baseline disease characteristics
| Recipients from male donors n = 109 | Recipients from female donors n = 36 | P value | |
|---|---|---|---|
| Aetiology of end stage heart failure | |||
| Ischemic heart disease (%) | 71 | 64 | 0.42 |
| Dilated cardiomyopathy (%) | 21 | 19 | 0.83 |
| Status of heart transplant waiting list candidates: | |||
| Status 1A (%) | 20 | 25 | 0.84 |
| Status 1B (%) | 42 | 39 | |
| Status 2 (%) | 38 | 36 | |
| ICD (%) | 23 | 22 | 0.96 |
| Assist device (%) | 20 | 14 | 0.39 |
| Creatinine (mg/dL) | 1.9 ± 4.9 | 1.5 ± 0.6 | 0.63 |
| Bilirubin (mg/dL) | 2.0 ± 6.5 | 1.3 ± 1.1 | 0.57 |
| Systolic pulmonary artery pressure (mmHg) | 55 ± 20 | 50 ± 20 | 0.36 |
| Diastolic pulmonary artery pressure (mmHg) | 27 ± 10 | 26 ± 12 | 0.55 |
| Mean pulmonary artery pressure (mmHg) | 38 ± 13 | 36 ± 14 | 0.41 |
| Pulmonary wedge pressure (mmHg) | 27 ± 10 | 25 ± 13 | 0.43 |
| Cardiac output (L/min) | 3.7 ± 1.1 | 3.2 ± 0.8 | 0.06 |
| Transpulmonary pressure gradient (mmHg) | 11.4 ± 7.5 | 11.1 ± 6.6 | 0.85 |
| Duration of hospitalization: from admission to transplantation (days) | 76 ± 134 | 39 ± 60 | 0.03 |
| PRA (mean, %) | 0.79 ± 4.9 | 1.08 ± 3.9 | 0.78 |
| Blood type | |||
| A (%) | 50 | 44 | 0.81 |
| AB (%) | 14 | 17 | |
| B (%) | 18 | 17 | |
| O (%) | 18 | 22 |
Values are mean ± SD, or percentage.